Southwestern Eye Center, Ltd. has completed a recapitalization with H.I.G. Capital
April 2017 — Southwestern Eye Center, Ltd. (SW Eye) has completed a recapitalization with H.I.G. Capital.
Founded in 1982, SW Eye is one of the largest eye care physician practices in the southwest, providing comprehensive optometry and ophthalmology services, including subspecialty procedures in vitreoretinal disease, oculoplastics, cornea disease, glaucoma, refractive procedures, low vision aids and ocular prosthetics through 23 locations in Arizona and one in New Mexico. SW Eye employs 17 ophthalmologists and 21 optometrists and is headquartered in Mesa, Arizona. The company is a highly regarded clinical organization with leadership positions in various academic organizations and industry trade groups.
H.I.G. Capital is a leading global private equity and alternative assets investment firm with US$21 billion of equity capital under management. Based in Miami and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the US, as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Mexico City and Rio de Janeiro, H.I.G. Capital specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused value-added approach. Since its founding in 1993, the firm has invested in and managed more than 200 companies worldwide. Its current portfolio includes more than 100 companies with combined sales in excess of US$30 billion.
Our role in the transaction
Oaklins' team in Los Angeles acted as financial advisor to the seller in this transaction.
Talk to the deal team
Gary Rabishaw
Oaklins Intrepid
Kyle Kearney
Oaklins Intrepid
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreComtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn more